Venous thromboembolic disease affects millions of patients throughout the world annually. Patient suffering from chronic sequalae of venous disease, such as post-thrombotic syndrome, can have clinical relief from venous stenting. However, the long-term outcomes of venous stents in post-thrombotic syndrome have not improved in recent years and represents a significant unmet need.
WHAT WE DO
Auxetics is a biomechanically driven company focused on developing a venous stent to address the unique biomechanical aspects of veins. For over 30 years, stents have focused on radial force and flexibility as their predominant characteristics. By studying and defining the biomechanical properties unique to veins, Auxetics has developed a fundamental change in the approach to stent research & development.